Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: A double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
J. Nam, E. Villeneuve, E.M.A. Hensor, P.G. Conaghan, Helen Keen, M.H. Buch, A.K.S. Gough, M.J. Green, P.S. Helliwell, A.M. Keenan, A.W. Morgan, M.A. Quinn, R.J. Reece, D.M.F.M. Van Der Heijde, R.J. Wakefield, P.D. Emery
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: A double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)'. Together they form a unique fingerprint.